Generic Placeholder Website Image

Activity content starts in:

Industry Webcast

Exploring Bleeding Risk with Select Anticoagulants for Acute VTE: Findings from a Registrational Trial and the First Head-to-Head Randomized Trial of DOACsIndustry Webcast Sponsored by Bristol Myers Squibb and Pfizer, Inc.; Not for CME/CE Credit

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 11/18/2026

Expiration Date: 11/18/2026

Topics

Faculty

Steven Deitelzweig, MD, MMM, FACC, SFHM, FACP, RVT

Learn More

Supporters and Partners

Industry Sponsor

Bristol Myers Squibb and Pfizer, Inc.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Exploring Bleeding Risk with Select Anticoagulants for Acute VTE: Findings from a Registrational Trial and the First Head-to-Head Randomized Trial of DOACs

Register